Gerresheimer AG/€GXI
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Gerresheimer AG
Gerresheimer AG is a prominent player in the healthcare and life sciences industry, specializing in the production of glass and plastic products for pharmaceutical and cosmetic packaging. The company’s key offerings include pharmaceutical vials, prefillable syringes, glass and plastic packaging for drugs, as well as delivery systems for the safe administration of medications. Founded in 1864, Gerresheimer has evolved into a global entity with headquarters in Düsseldorf, Germany, and operates manufacturing sites in Europe, the Americas, and Asia. Its strategic strength lies in a broad product portfolio and advanced technical expertise, enabling it to cater to the stringent requirements of its diverse clientele in the healthcare sector. The company’s comprehensive geographic footprint and commitment to innovation bolster its competitive position in the market.
Ticker
€GXI
Sector
Primary listing
XETRA
Employees
13,616
Headquarters
Website
Gerresheimer AG Metrics
BasicAdvanced
€1.5B
23.85
€1.83
0.78
€0.04
0.09%
Price and volume
Market cap
€1.5B
Beta
0.78
52-week high
€107.21
52-week low
€41.52
Average daily volume
33K
Dividend rate
€0.04
Financial strength
Current ratio
1.007
Quick ratio
0.438
Long term debt to equity
116.089
Total debt to equity
158.647
Dividend payout ratio (TTM)
68.25%
Interest coverage (TTM)
2.02%
Profitability
EBITDA (TTM)
414.302
Gross margin (TTM)
28.07%
Net profit margin (TTM)
2.89%
Operating margin (TTM)
9.14%
Effective tax rate (TTM)
23.32%
Revenue per employee (TTM)
€160,000
Management effectiveness
Return on assets (TTM)
3.01%
Return on equity (TTM)
4.45%
Valuation
Price to earnings (TTM)
23.849
Price to revenue (TTM)
0.69
Price to book
1.04
Price to tangible book (TTM)
-4.99
Price to free cash flow (TTM)
-3.227
Free cash flow yield (TTM)
-30.99%
Free cash flow per share (TTM)
-13.536
Dividend yield (TTM)
0.09%
Forward dividend yield
0.09%
Growth
Revenue change (TTM)
9.32%
Earnings per share change (TTM)
-45.04%
3-year revenue growth (CAGR)
10.23%
10-year revenue growth (CAGR)
5.22%
3-year earnings per share growth (CAGR)
-11.27%
10-year earnings per share growth (CAGR)
-1.86%
3-year dividend per share growth (CAGR)
-68.25%
10-year dividend per share growth (CAGR)
-25.41%
Bulls say / Bears say
Shares surged nearly 4% on August 5 after Gerresheimer announced plans to sell its moulded glass business, showing investor confidence in improved growth and margins from its focus on pharma and biotech packaging (Reuters).
Gerresheimer reaffirmed its medium-term organic revenue growth target of 6–9% and an adjusted EBITDA margin of 23–25%, underscoring management’s confidence in sustainable profitability improvements (Reuters).
CEO Dietmar Siemssen reiterated strong long-term prospects for containment solutions and drug delivery systems for biologics, especially GLP-1 injection pens for weight-loss drugs like Wegovy, leveraging a fast-growing market (Reuters).
Gerresheimer cut its 2025 revenue outlook for the second time to just 0–2% organic growth, underlining ongoing weak demand in the cosmetics and oral liquids segments (Reuters).
Active Ownership, which now holds a 5.31% stake in Gerresheimer, has called for a faster strategic review and cost cuts after shares dropped 36% year-to-date, signaling shareholder dissatisfaction with management execution (Reuters).
The company cut its dividend for the 2024 financial year to €0.04 per share from €1.25 to safeguard financial flexibility, potentially reducing shareholder returns and highlighting cash-flow pressures (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 30 Aug 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Gerresheimer AG stock?
Gerresheimer AG (GXI) has a market cap of €1.5B as of September 03, 2025.
What is the P/E ratio for Gerresheimer AG stock?
The price to earnings (P/E) ratio for Gerresheimer AG (GXI) stock is 23.85 as of September 03, 2025.
Does Gerresheimer AG stock pay dividends?
Yes, the Gerresheimer AG (GXI) stock pays dividends to shareholders. As of September 03, 2025, the dividend rate is €0.04 and the yield is 0.09%. Gerresheimer AG has a payout ratio of 68.25% on a trailing twelve-month basis.
When is the next Gerresheimer AG dividend payment date?
The next Gerresheimer AG (GXI) dividend payment date is unconfirmed.
What is the beta indicator for Gerresheimer AG?
Gerresheimer AG (GXI) has a beta rating of 0.78. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.